As BioNTech progresses with its goal to grow into a “fully integrated immunotherapy powerhouse,” the German biotech is e | ...

Azithromycin has been widely evaluated for its efficacy against COVID-19. The study by Timothy S C Hinks and colleagues1 adds value to the current literature, and we would like to share our comments.

or biotech startup Treeline Biosciences find new drug candidates by simulating molecules. Sign up here. Its software was originally written with central processor units, or CPUs, in mind during an ...

a Kansas City-based biotech company, led to the company winning a grant for development of a new HIV therapy. What it takes for KC pharma companies to face the 'valley of death' KC takes its shot ...

ImmunityBio's ANKTIVA sBLA for papillary bladder cancer was rejected by the FDA despite prior support, prompting the company ...

The biotech previously disclosed AlpineBrook convertible notes. NKGen said Song has invested to try to accelerate its phase 2 trial, reduce its payables and cover the expenses it incurs as a ...

Unity’s restructuring comes along with 36-week results from its phase 2b Aspire trial that ... co-founder and CEO Trevor Martin confirmed with Fierce Biotech in an emailed statement.

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

We are transferring coverage of Sartorius AG and its subsidiary Sartorius Stedim Biotech—both active in biopharmaceutical equipment and laboratory consumables—to a new analyst. Sartorius ...

The Trump administration’s sweeping cuts of federal research funding and its fight with Harvard University risk bleeding into the venture capital market, curbing financing opportunities for ...

The third of its kind from Deerfield ... Those investments were tallied during a recalibration of biotech venture funding, with venture firms coalescing around a smaller number of surer bets ...